[ Back to EurekAlert! ]

Contact: Michael C. Purdy
purdym@wustl.edu
314-286-0122
Washington University School of Medicine

ALS Protein

Caption: A mutated protein that causes an inherited form of Lou Gehrig's disease leads to clumps in the human cells in the bottom image. A therapy that blocks production of this protein has passed phase one safety trials.

Credit: Matthew J. Crisp

Usage Restrictions: Please include credit.

Related news release: ALS trial shows novel therapy is safe


[ Back to EurekAlert! ]